Maroney Dawn Christine
Maroney Dawn Christine, PRES, reported an open-market or private sale at Alignment Healthcare, Inc. involving 122707.000000 shares for an estimated $1555924.76. Reported holdings after the transaction were 794606.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 11, 2026
- Filing date
- Sep 12, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 917,313 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ALHC price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001628280-26-061621 Common Stock
- Transaction date
- Sep 11, 2026 Filed Sep 12, 2026, 12:41 AM · 1d delay
- Shares
- 122,707 sh $12.68 per share
- Estimated value
- -$1.55M Computed from shares × price
- Holdings after
- 794,606 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President
- F1
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not rep…
- F2
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.394 to $13.17. The reporting person undertakes to provide to…
0 other transactions
0 recent txs